UTAH MEDICAL PRODUCTS INC

Utah Medical Products, Inc. (NASDAQ: UTMD) operates as a specialized medical device manufacturer focused on producing high-quality, cost-effective devices differentiated by safety and improved patient outcomes. The company's website is www.utahmed.com.

UTMD designs, manufactures, and distributes medical devices predominantly used in critical care settings, particularly neonatal intensive care units, labor and delivery departments, and women's health centers within hospitals, as well as outpatient clinics and physician offices. The company's product portfolio spans several therapeutic areas including fetal monitoring accessories, specialized labor and delivery tools, vacuum-assisted delivery systems, neonatal intensive care devices, gynecological and urological instruments, electrosurgery equipment, and pressure monitoring systems.

The company's major product lines include the INTRAN PLUS intrauterine pressure catheter system, the Filshie Clip System for tubal ligation, the LETZ electrosurgery system, neonatal catheters and feeding devices under the Gesco brand, the Deltran blood pressure monitoring system, and the Disposa-Hood respiratory hood for neonates. In 2025, Filshie Clip System sales represented 26 percent of total U.S. dollar-denominated sales, while products from four key acquisitions comprised 57 percent of consolidated sales.

UTMD operates manufacturing and distribution facilities in the United States, Ireland, United Kingdom, Australia, Canada, and France. The company maintains direct distribution relationships in Canada, the UK, France, Ireland, Australia, and New Zealand, while reaching additional markets through approximately 200 independent distributors globally. Outside the United States represented 41 percent of consolidated sales in 2025.

The company was incorporated in Utah in 1978 and has grown through strategic acquisitions including Columbia Medical in 1997, Gesco International's neonatal product line in 1998, Abcorp in 2004, and Femcare Holdings Ltd in 2011. UTMD also generates revenue through original equipment manufacturer sales, providing components and finished devices to other medical device companies. Since 1992, the company has returned over $246 million to shareholders through share repurchases and dividends.